CliffBio
small molecule

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Active ingredientBETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
StrengthEQ 0.05% BASE;1%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalMay 2001
Marketing statusRX

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.